3,688
edits
Vascular/Lymphatic Malformation: Difference between revisions
no edit summary
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Stub Notice}} | {{Stub Notice}} | ||
Bleomycin | <b>Bleomycin</b> | ||
[https://pubmed.ncbi.nlm.nih.gov/88070/ The hazards of anesthesia and surgery in bleomycin-treated patients] | [https://pubmed.ncbi.nlm.nih.gov/88070/ The hazards of anesthesia and surgery in bleomycin-treated patients] | ||
[https://www.jvir.org/article/S1051-0443(18)31591-4/fulltext Hyperpigmentation after Foamed Bleomycin Sclerotherapy for Vascular Malformations] | [https://www.jvir.org/article/S1051-0443(18)31591-4/fulltext Hyperpigmentation after Foamed Bleomycin Sclerotherapy for Vascular Malformations] | ||